Skip to main content

Table 1 Clinical characteristics of all patients at baseline and follow-up

From: Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis

  Baseline Follow-up
Creatinine, μmol/L 92.3 (46.6) 81.6 (42.6)
Proteinuria, g/day 2.0 (1.8) 0.7 (0.8)
C3, g/L 0.53 (0.23) 0.80 (0.23)
C4, g/L 0.09 (0.06) 0.13 (0.07)
C1q 66.6% (41.0%) 75.2% (29.5%)
Anti-dsDNA-positivea 83% 44%
Glomerular filtration rate 80.7 (29.4) 88.6 (26.4)
U-erythrocytes > 1+ 79% 46%
Renal histology, number   
   Class I 15 1
   Class II 12 13
   Class III 2 6
   Class IV 6 3
   Class III/V   12
   Class V   
Activity index 5.7 (3.1) 2.5 (2.3)
Chronicity index 1.8 (2.0) 2.3 (2.3)
Treatment, number   
   Cyclophosphamide 21  
   Mycophenolate mofetil 8  
   Rituximab 5  
   Azathioprin 1  
BILAG renal index, number   
   A 32 2
   B 3 18
   C   7
   D   8
  1. Values are presented as mean (standard deviation) unless otherwise indicated. aAnti-double-stranded DNA (anti-dsDNA) raised to at least 1:25. BILAG, British Isles lupus assessment group.